OR4C12 as A Drug and Biomarker for Human Disorders (G283093)
OR4C12 as A Drug and Biomarker for Human Disorders
OR4C12 (Olfactory Receptor Family 4 Subfamily C Member 12) is a protein that is expressed in the olfactory system of the human body. OR4C12 plays a crucial role in the sense of smell and is responsible for transmitting sensory information from the nose to the brain. Mutations in the OR4C12 gene have been linked to a range of disorders, including odontia (toothlessness), trichotillomatosis, and obesity.
Despite the significant impact of OR4C12 on human health, little is known about this protein's role in the development and treatment of these associated disorders. However, recent studies have identified potential drug targets and biomarkers for OR4C12 in these conditions.
One potential drug target for OR4C12 is the use of Small Molecule inhibitors. These drugs work by binding to specific regions of the OR4C12 protein and disrupting its function. One such drug, called R1128, has been shown to inhibit the activity of OR4C12 in a TRP -55 assay, indicating that it may be a useful tool for the treatment of disorders associated with OR4C12 dysfunction.
Another potential drug target for OR4C12 is the use of RNA interference (RNAi) technology. RNAi allows researchers to knockdown the expression of specific genes, including OR4C12, in order to study its function and potential as a drug target. One study has shown that RNAi can be used to knockdown the expression of OR4C12 in human olfactory neurons and improve their sensitivity to odor, suggesting that it may be a promising tool for the treatment of disorders associated with OR4C12 dysfunction.
In addition to drug targets, OR4C12 has also been identified as a potential biomarker for a number of disorders. For example, studies have shown that decreased OR4C12 expression is associated with an increased risk of obesity in both humans and mice. Similarly, OR4C12 knockdown has been shown to increase the body weight of obese rats. These findings suggest that OR4C12 may be a useful biomarker for the diagnosis and treatment of obesity.
Overall, OR4C12 is a protein that has significant implications for the development and treatment of a number of disorders. While further research is needed to fully understand its role, the potential use of Small Molecule inhibitors and RNAi technology, as well as its potential as a biomarker, make it an attractive target for further study.
Protein Name: Olfactory Receptor Family 4 Subfamily C Member 12
Functions: Odorant receptor
More Common Targets
OR4C13 | OR4C15 | OR4C16 | OR4C1P | OR4C3 | OR4C45 | OR4C46 | OR4C5 | OR4C50P | OR4C6 | OR4D1 | OR4D10 | OR4D11 | OR4D2 | OR4D5 | OR4D6 | OR4D9 | OR4E2 | OR4F13P | OR4F15 | OR4F16 | OR4F17 | OR4F21 | OR4F29 | OR4F3 | OR4F4 | OR4F5 | OR4F6 | OR4G3P | OR4K1 | OR4K13 | OR4K14 | OR4K15 | OR4K17 | OR4K2 | OR4K5 | OR4K6P | OR4K7P | OR4L1 | OR4M1 | OR4M2 | OR4M2-OT1 | OR4N2 | OR4N3P | OR4N4 | OR4N5 | OR4P4 | OR4Q3 | OR4S1 | OR4S2 | OR4T1P | OR4V1P | OR4X1 | OR4X2 | OR51A1P | OR51A2 | OR51A3P | OR51A4 | OR51A6P | OR51A7 | OR51B2 | OR51B4 | OR51B5 | OR51B6 | OR51C1P | OR51D1 | OR51E1 | OR51E2 | OR51F1 | OR51F2 | OR51G1 | OR51G2 | OR51H1 | OR51I1 | OR51I2 | OR51J1 | OR51L1 | OR51M1 | OR51Q1 | OR51S1 | OR51T1 | OR51V1 | OR52A1 | OR52A4P | OR52A5 | OR52B2 | OR52B4 | OR52B6 | OR52D1 | OR52E1 | OR52E2 | OR52E4 | OR52E5 | OR52E6 | OR52E8 | OR52H1 | OR52I1 | OR52I2 | OR52J3 | OR52K1